BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1506705)

  • 21. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators.
    von Segesser LK; Turina M
    J Thorac Cardiovasc Surg; 1989 Sep; 98(3):386-96. PubMed ID: 2770320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hydrophilic coating on microorganism colonization in silicone tubing.
    Cağavi F; Akalan N; Celik H; Gür D; Güçiz B
    Acta Neurochir (Wien); 2004 Jun; 146(6):603-10; discussion 609-10. PubMed ID: 15168229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can protamine be used during perfusion with heparin surface coated equipment?
    von Segesser LK; Gyurech DD; Schilling JJ; Marquardt K; Turina MI
    ASAIO J; 1993; 39(3):M190-4. PubMed ID: 8268526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surgery of abdominal aorta with horseshoe kidney].
    Lotina SL; Davidović LB; Kostić DM; Velimirović DV; Petrović PLj; Perisić-Savić MV; KovacevićN S
    Srp Arh Celok Lek; 1997; 125(1-2):36-44. PubMed ID: 17974353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonthrombogenic materials via a simple coating process.
    Grode GA; Anderson SJ; Grotta HM; Falb RD
    Trans Am Soc Artif Intern Organs; 1969; 15():1-6. PubMed ID: 5791389
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children.
    Eisses MJ; Geiduschek JM; Jonmarker C; Cohen GA; Chandler WL
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):28-34. PubMed ID: 17289476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of proximal aortic anastomosis device in coronary artery bypass grafting].
    Sugimoto T; Yamamoto K; Sakakibara K; Uehara A; Mishima T; Sato M; Yoshii S; Kasuya S
    Kyobu Geka; 2009 Mar; 62(3):175-8; discussion 179-81. PubMed ID: 19280945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of the use of artificial arteriovenous shunt of Scribner.
    Szepietowski T; Kurbiel A; Kaplicki M
    Pol Med J; 1970; 9(2):445-52. PubMed ID: 4915321
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboresistant polymers: a new approach.
    Wilson JE; Jones CE
    Biomater Artif Cells Artif Organs; 1989; 17(4):437-45. PubMed ID: 2605357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymeric materials: current status of biocompatibility.
    Bruck SD
    Biomater Med Devices Artif Organs; 1973; 1(1):79-98. PubMed ID: 4766640
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombogenicity of Teflon versus copolymer-coated guidewires: evaluation with scanning electron microscopy.
    Pinto RS; Robbins E; Seidenwurm D
    AJNR Am J Neuroradiol; 1989; 10(2):407-10. PubMed ID: 2494862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of materials for use as prosthetic heart valve leaflets in a simple biologic model.
    Hessel EA; Anderson HN; Merendino KA
    Ann Surg; 1966 Dec; 164(6):1013-20. PubMed ID: 5926239
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro considerations in the production of dimensionally accurate earmoulds. II. The earmould material.
    Combe EC; Nolan M
    Scand Audiol; 1989; 18(2):67-73. PubMed ID: 2756335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of siliclad; a new silicone material.
    FISHER LM; JAQUES LB
    J Appl Physiol; 1958 Nov; 13(3):527-8. PubMed ID: 13587447
    [No Abstract]   [Full Text] [Related]  

  • 40. Contaminated Bypass Equipment.
    Kuehn B
    JAMA; 2019 Feb; 321(6):538. PubMed ID: 30747973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.